お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
635924

世界の血管アクセスデバイス市場:デバイスタイプ別、用途別、エンドユーザー別、地域別動向 - 成長、動向、予測

Vascular Access Devices Market - Growth, Trends, and Forecast (2019 - 2024)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.87円
世界の血管アクセスデバイス市場:デバイスタイプ別、用途別、エンドユーザー別、地域別動向 - 成長、動向、予測
出版日: 2019年05月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 111 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の血管アクセスデバイス市場について調査し、市場の概要とデバイスタイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な推論

第5章 市場概要

  • 現在の市場シナリオ
  • ポーターズファイブフォース分析

第6章 市場動向

  • 市場促進因子
  • 市場阻害因子
  • 機会
  • 主な課題

第7章 市場セグメンテーション

  • デバイスタイプ別
    • 中心血管アクセスデバイス
    • 抹消血管アクセスデバイス
  • 用途別
    • 薬剤投与
    • 液体・栄養投与
    • 診断・検査
    • その他
  • エンドユーザー別
    • 病院/診療所
    • 診断センター
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 競合環境

  • 合併・買収分析
  • 協定、連携、提携
  • 新製品上市

第9章 主要参入企業

  • B. Braun Melsungen AG
  • Baxter
  • Becton, Dickinson and Company
  • Fresenius Medical Care AG & Co. KGaA
  • Medtronic PLC
  • ニプロ株式会社
  • Siemens Healthineers
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • テルモ株式会社

第10章 市場の将来

目次
Product Code: 60445

Market Overview

Over the last decade, there has been a rise in the prevalence of several chronic diseases that need vascular access treatment. Some of the major chronic diseases include cancer, kidney failure, and heart diseases, among others. Along with these, there are several lifestyle disorders relating to chronic and non-communicable disease conditions, such as hypertension, diabetes, obesity, and depression, among others, which need critical care during their hospitalization.

The prevalence of end-stage renal disease (ESRD), worldwide, is further increasing at a significant rate, resulting in chronic kidney disease (CKD). In 2017, in the United States, around 30 million people (15% of US adults) were suffering from chronic kidney disease (CKD). CKD was found to be more common in women (16%) than in men (13%). For patients undergoing dialysis treatment, the ideal method of vascular access is through an arteriovenous fistula (ANF), by referring to a nephrologist about replacement therapy. The vascular access catheter devices are also significantly used in the case of chemotherapies. According to the Center for Disease Control and Prevention (CDC), in the United States, nearly 0.65 million cancer patients receive chemotherapy in an outpatient oncology clinic annually. With the rising prevalence of chronic diseases and lifestyle disorders, the vascular access procedures are increasingly being used for intravenous antibiotic treatment, long intravenous nutritional support, and drawing of blood samples.

Thus, during the forecast period, a high rise is expected in the prevalence of these diseases, both in developed and highly emerging markets, such as India, China, and Middle Eastern countries, which are expected to draw an attention of several multinational medical devices companies to invest and launch new products, thus, acting as one of the major drivers for this market.

Scope of the Report

Vascular access devices (VADs) are inserted into the veins for diagnostic and therapeutic reasons, such as blood sampling, central venous pressure readings, administration of medication, fluids, total parenteral nutrition (TPN), and blood transfusions. These are inserted peripherally or centrally. The choice of device for each patient differs and multiple types of devices may be required at a time, as a single device may not be able to meet all the requirements.

Key Market Trends

Application Segment is Dominated by the Administration of Fluid and Nutrition

Despite the move toward increased patient involvement in the decisions affecting their care, there is little evidence published to support user involvement in the selection of vascular access devices. There is, however, increasing evidence of patient experiences linked with vascular access and infusion therapies.

Peripherally, inserted central catheters (PICC) are most commonly inserted via the basilic, brachial or cephalic veins for the parenteral delivery of nutrition. All patients undergoing emergency of elective surgery require monitoring of intravenous fluids and blood components through vascular access devices. In the case of ESRD and CKD, vascular access plays a highly essential role for fluid resuscitation, fluid administration, electrolytes, nutrition or medication, laboratory testing, and monitoring of hemodynamics. During advanced life support in hospitals, vascular access is a primary requirement for fluid administration. The range of applications, in which vascular access can be used for fluids transmission is high, including critically ill patients and children with shock, where intraosseous cannulation (IO) is highly important. IO access has a high success rate in critically ill children.

Short-term vascular access is frequently required by hospitalized children through fluids and nutrition. Some of the major companies helping fluid administration are Teleflex, 3M, Medline Industries, and Mobilex USA.

North America to Dominate the Market Over the Forecast Period

The demand for vascular access devices has increased in the United States in the past five years, with a high percentage of patients receiving some sort of vascular access treatment during their hospitalization.

The US Food and Drug Administration (FDA) proposed stringent guidelines, in terms of usage, owing to the increased vascular infections. The US FDA has released regulated guidelines for the hemodialysis vascular access, as well as certain laws and regulations affecting the use of these products, along with the guidelines to certain issues raised and end points proposed by the kidney health initiative. A high percentage of catheters, especially PICC, is being used by more than 80% of hemodialysis patients. An increase in the percentage of usage, with more than 90 days, is also recorded during the long stay of the patient.

Additionally, in a large number of cases of all the end-stage renal disease (ESRD), dialysis patients are treated via a catheter, which is performed in an outpatient setting, thus, reducing the hospitalization of ESRD patients by allowing the non-emergency interventional procedures to be carried out. The factors, such as government guidelines for the regulation of medical devices by the company, and better healthcare infrastructure, etc., play a key role in increasing the business and in the launching of new products by multinational companies, and thereby, contributing the market growth.

Competitive Landscape

The vascular access devices market is highly competitive and there are several small to mid-sized companies that are posing strong competition to gain the market share. However, few companies that are doing a good business in the market include B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, NIPRO Medical Corporation and Fresenius Medical Care.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Lifestyle-related Disorders
    • 4.2.2 Increasing Number of Chemotherapy Procedures with High Hospitalization Rates
    • 4.2.3 Rising Use of Vascular Access Devices among Pediatric Patients
    • 4.2.4 Rising Medical Tourism
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Catheter Use
    • 4.3.2 Stringent Regulations
    • 4.3.3 Product Recalls and Failures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Device Type
    • 5.1.1 Central Vascular Access Devices
      • 5.1.1.1 Peripherally Inserted Central Catheters
      • 5.1.1.2 Tunneled Catheters
      • 5.1.1.3 Percutaneous Non-tunneled Catheters
      • 5.1.1.4 Implanted Ports
      • 5.1.1.5 Others
    • 5.1.2 Peripheral Vascular Access Devices
      • 5.1.2.1 Peripheral Catheter
      • 5.1.2.2 Midline Catheter
      • 5.1.2.3 Others
  • 5.2 By Application
    • 5.2.1 Administration of Drugs
    • 5.2.2 Administration of Fluid and Nutrition
    • 5.2.3 Diagnotics and Testing
    • 5.2.4 Others
  • 5.3 By End User
    • 5.3.1 Hospital/Clinic
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B.Braun Melsungen AG
    • 6.1.2 Baxter
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Fresenius Medical Care AG & Co. KGaA
    • 6.1.5 Medtronic PLC
    • 6.1.6 Nipro Medical Corporation
    • 6.1.7 Siemens Healthineers
    • 6.1.8 Smiths Medical Inc.
    • 6.1.9 Teleflex Incorporated
    • 6.1.10 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.